Literature DB >> 25219594

A pilot trial of quantitative Epstein-Barr virus polymerase chain reaction in patients undergoing treatment for their malignancy: potential use of Epstein-Barr virus polymerase chain reaction in multiple cancer types.

Donald E Tsai1, Marlise R Luskin, Brandon E Kremer, Albert K Chung, Sharon Arnoldi, Vikram R Paralkar, Sunita D Nasta, Edward A Stadtmauer, Stephen J Schuster, Marin Xavier.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25219594     DOI： 10.3109/10428194.2014.963577

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  4 in total

1.  The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder.

Authors:  M R Luskin; D S Heil; K S Tan; S Choi; E A Stadtmauer; S J Schuster; D L Porter; R H Vonderheide; A Bagg; D F Heitjan; D E Tsai; R Reshef
Journal:  Am J Transplant       Date:  2015-05-18       Impact factor: 8.086

2.  When kissing (disease) counts.

Authors:  Katrien Van Roosbroeck; George A Calin
Journal:  Blood       Date:  2016-04-21       Impact factor: 22.113

3.  The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases.

Authors:  Jennifer A Kanakry; Aparna M Hegde; Christine M Durand; Allan B Massie; Amy E Greer; Richard F Ambinder; Alexandra Valsamakis
Journal:  Blood       Date:  2016-01-07       Impact factor: 22.113

4.  High prevalence of plasma EBV DNA among the HIV positive individuals, with or without malignancies, attending the clinic at AIIMS, New Delhi.

Authors:  Dibyakanti Mandal; Devashish Desai; Sanjeev Sinha
Journal:  Virusdisease       Date:  2021-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.